Acute Lymphoblastic Leukemia is a fast growing type of blood cancer. The cancer is characterized by the high levels of lymphoblasts in both the blood and bone marrow. The cancer can then spread to other organs in the body and without treatment Acute Lymphoblastic Leukemia will progress very quickly. Acute Lymphoblastic Leukemia may arise from transformation of B or T cell progenitor cells. Once there are no traces of leukemia in the body through a series of tests the patient is considered to be in remissiom. Although it is not garunteed that the leukemia witll continue to be in remission, often a petient will go through a relapse where the cancer returns.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Recurrent Childhood Acute Lymphoblastic Leukemia below!
For more information on how to use Laverne, please read the How to Guide.
We have 1196 products for the study of Recurrent Childhood Acute Lymphoblastic Leukemia that can be applied to Chromatin Immunoprecipitation, Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.
Recurrent Childhood Acute Lymphoblastic Leukemia is also known as Recurrent Childhood All, Relapsed Childhood Acute Lymphoblastic Leukemia, Relapsed Childhood Acute Lymphocytic Leukemia, Relapsed Childhood All, Relapsed Pediatric Acute Lymphoblastic Leukemia.